Abbisko Cayman Limited

Abbisko Cayman Limitedverified

2256.HK

Price:

$13.44

Market Cap:

$8.01B

Abbisko Cayman Limited, a clinical-stage biopharmaceutical company, discovers and develops small molecule oncology therapies in the People's Republic of China. Its product candidates are primarily small molecules that focus on small molecule precision oncology and small molecule immuno-oncology therapeutic areas. The company's primary product candidates are ABSK011, a small molecule inhibitor of fibroblast growth factor receptor 4 for the treatment of advanced hepatocellular carcinoma with hyper-activation of FGF19/FGFR4 signaling; and ABSK091, a molecularly targeted product candidate for the treatment of multiple solid tumors, including urothelial cancer, gastric cancer, cholangiocarcinoma,...[Read more]

Industry

Biotechnology

IPO Date

2021-10-13

Stock Exchange

HKSE

Ticker

2256.HK

The ROE as of December 2025 (TTM) for Abbisko Cayman Limited (2256.HK) is 7.17%

According to Abbisko Cayman Limited’s latest financial reports and current stock price. The company's current ROE is 7.17%. This represents a change of 406.67% compared to the average of 1.42% of the last 4 quarters.

Abbisko Cayman Limited (2256.HK) Historical ROE (quarterly & annually)

How has 2256.HK ROE performed in the past?

The mean historical ROE of Abbisko Cayman Limited over the last ten years is -3.28%. The current 7.17% ROE has changed -318.94% with respect to the historical average. Over the past ten years (40 quarters), 2256.HK's ROE was at its highest in in the June 2021 quarter at 20.11%. The ROE was at its lowest in in the September 2021 quarter at -28.25%.

Quarterly (TTM)
Annual

Average

-3.28%

Median

-9.90%

Minimum

-71.18%

Maximum

63.97%

Abbisko Cayman Limited (2256.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Abbisko Cayman Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 119.62%

Maximum Annual ROE = 63.97%

Minimum Annual Increase = -211.27%

Minimum Annual ROE = -71.18%

Quarterly (TTM)
Annual
YearROEChange
20241.45%-106.63%
2023-21.78%2.58%
2022-21.24%-70.16%
2021-71.18%-211.27%
202063.97%119.62%

Abbisko Cayman Limited (2256.HK) Average ROE

How has 2256.HK ROE performed in the past?

The current ROE of Abbisko Cayman Limited (2256.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-13.86%

5-year avg

-9.76%

10-year avg

-3.28%

Abbisko Cayman Limited (2256.HK) ROE vs. Peers

How is 2256.HK’s ROE compared to its peers?

Abbisko Cayman Limited’s ROE is greater than CARsgen Therapeutics Holdings Limited (-39.53%), less than Alphamab Oncology (12.63%), less than HBM Holdings Limited (18.28%), greater than Ascletis Pharma Inc. (-13.49%), greater than CStone Pharmaceuticals (-71.29%), less than Nanjing Leads Biolabs Co Ltd (0%), less than Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (15.32%), less than IVD Medical Holding Limited (4.85%), greater than CK Life Sciences Int'l., (Holdings) Inc. (-7.77%), greater than Lepu Biopharma Co., Ltd. (-24.47%),

Build a custom stock screener for Abbisko Cayman Limited (2256.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abbisko Cayman Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abbisko Cayman Limited (2256.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abbisko Cayman Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Abbisko Cayman Limited's ROE?

How is the ROE calculated for Abbisko Cayman Limited (2256.HK)?

What is the highest ROE for Abbisko Cayman Limited (2256.HK)?

What is the 3-year average ROE for Abbisko Cayman Limited (2256.HK)?

What is the 5-year average ROE for Abbisko Cayman Limited (2256.HK)?

How does the current ROE for Abbisko Cayman Limited (2256.HK) compare to its historical average?